References
- Farzaei MH, Bahramsoltani R, Rahimi R. Phytochemicals as adjunctive with conventional anticancer therapies. Curr Pharm Des. 2016;22(27):4201–4218. doi:https://doi.org/10.2174/1381612822666160601100823
- Wall-Medrano A, Olivas-Aguirre FJ. Antioxidant phytochemicals in cancer prevention and therapy—An update. Functional foods in cancer prevention and therapy. Elsevier Inc., United Kingdom: 2020. p. 195–220.
- Shippee BM, Bates JS, Richards KL. The role of screening and monitoring for bleomycin pulmonary toxicity. J Oncol Pharm Pract. 2016;22(2):308–312. doi:https://doi.org/10.1177/1078155215574294
- Baruch DJ, Andrea D, Webster PM, Neil HS. Methotrexate-induced pulmonary toxicity. Can Respir J. 2013;20(3):153–155. doi:https://doi.org/10.1155/2013/527912
- Kileci JA, Charran O, Filopei J, Pulmonary D, Care C, Medicine S. Severe methotrexate-induced pulmonary toxicity: d34 Lung transplant and drug induced lung disease: case reports. Paper presented at American Thoracic Society 2018 International Conference, Area J (Hall A-B2, Ground Level) San Diego Convention Center, USA; 2018. Retrieved from https://doi.org/10.1164/ajrccm-conference.2018.D34
- Ichikawa S, Fukuhara N, Saito K, Onodera K, Shirai T, Onishi Y, Yokoyama H, Fujii H, Ichinohasama R, Harigae H, et al. Successful treatment of methotrexate-associated classical Hodgkin lymphoma with brentuximab vedotin-combined chemotherapy: a case series. Int J Hematol. 2020;111(5):667–672. doi:https://doi.org/10.1007/s12185-020-02822-z
- Khan N, Syed DN, Ahmad N, Mukhtar H. Fisetin: A dietary antioxidant for health promotion. Antioxid Redox Signal. 2013;19(2):151–162. doi:https://doi.org/10.1089/ars.2012.4901
- Ethiraj S, Gopinath S. Production, purification, characterization, immobilization, and application of Serrapeptase: a review. Front Biol. 2017;12(5):333–348. doi:https://doi.org/10.1007/s11515-017-1461-3
- Muramatsu Y, Sugino K, Ishida F, Tatebe J, Morita T, Homma S. Effect of inhaled N-acetylcysteine monotherapy on lung function and redox balance in idiopathic pulmonary fibrosis. Respir Investig. 2016;54(3):170–178. doi:https://doi.org/10.1016/j.resinv.2015.11.004
- Tiwari M. The role of serratiopeptidase in the resolution of inflammation. Asian J Pharm Sci. 2017;12(3):209–215. doi:https://doi.org/10.1016/j.ajps.2017.01.003
- Lago JHG, Toledo-Arruda AC, Mernak M, Barrosa KH, Martins MA, Tibério IFLC, Prado CM. Structure-activity association of flavonoids in lung diseases. Molecules. 2014;19(3):3570–3595. doi:https://doi.org/10.3390/molecules19033570
- Thrall RS, McCormick JR, Jack RM, McReynolds RA, Ward PA. Bleomycin-induced pulmonary fibrosis in the rat. Inhibition by indomethacin. Am J Pathol. 1979;95(1):117–130.
- Moron MS, Depierre JW, Mannervik B. Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver. BBA - Gen Subj. 1979;582(1):67–78. doi:https://doi.org/10.1016/0304-4165(79)90289-7
- Chakraborty S, Nandi A, Mukhopadhyay M, Mukhopadhyay CK, Chatterjee IB. Ascorbate protects guinea pig tissues against lipid peroxidation. Free Radic Biol Med. 1994;16(4):417–426. doi:https://doi.org/10.1016/0891-5849(94)90118-X
- Petruska JM, Wong SHY, Sunderman FW, Mossman BT. Detection of lipid peroxidation in lung and in bronchoalveolar lavage cells and fluid. Free Radic Biol Med. 1990;9(1):51–58. doi:https://doi.org/10.1016/0891-5849(90)90049-O
- Kliment CR, Englert JM, Crum LP, Oury TD. A novel method for accurate collagen and biochemical assessment of pulmonary tissue utilizing one animal. Int J Clin Exp Pathol. 2011;4(4):349–355.
- Reddy GK, Enwemeka CS. A simplified method for the analysis of hydroxyproline in biological tissues. Clin Biochem. 1996;29(3):225–229. doi:https://doi.org/10.1016/0009-9120(96)00003-6
- Huszar G, Maiocco J, Naftolin F. Monitoring of collagen and collagen fragments in chromatography of protein mixtures. Anal Biochem. 1980;105(2):424–429. doi:https://doi.org/10.1016/0003-2697(80)90481-9
- Stegemann H, Stalder K. Determination of hydroxyproline. Clin Chim Acta. 1967;18(2):267–273. doi:https://doi.org/10.1016/0009-8981(67)90167-2
- Wingo PA, Ries LA, Giovino GA, Miller DS, Rosenberg HM, Shopland DR, Thun MJ, Edwards BK. Annual report to the nation on the status of cancer, 1973-1996, with a special section on lung cancer and tobacco smoking. J Natl Cancer Inst. 1999;91(8):675–690. doi:https://doi.org/10.1093/jnci/91.8.675
- Zhang Y-J, Gan R-Y, Li S, Zhou Y, Li A-N, Xu D-P, Li H-B. Antioxidant phytochemicals for the prevention and treatment of chronic diseases. Molecules. 2015;20(12):21138–21156. doi:https://doi.org/10.3390/molecules201219753
- Comeglio P, Filippi S, Sarchielli E, Morelli A, Cellai I, Corcetto F, Corno C, Maneschi E, Pini A, Adorini L, et al. Anti-fibrotic effects of chronic treatment with the selective FXR agonist obeticholic acid in the bleomycin-induced rat model of pulmonary fibrosis. J Steroid Biochem Mol Biol. 2017;168:26–37. doi:https://doi.org/10.1016/j.jsbmb.2017.01.010
- Arpag H, Gül M, Aydemir Y, Atilla N, Yiğitcan B, Cakir T, Polat C, Þehirli Ö, Sayan M. Protective effects of alpha-lipoic acid on methotrexate-induced oxidative lung injury in rats. J Invest Surg. 2018;31(2):107–113. doi:https://doi.org/10.1080/08941939.2017.1296513
- Khokar A, Schneider J, Cheriyan C, Ali Z, Nair GB. Expert opinion: Pulmonary toxicity related with chemotherapeutic agents. J Symp Sign. 2014;3(5):330–340.
- Williamson JD, Sadofsky LR, Hart SP. The pathogenesis of bleomycin-induced lung injury in animals and its applicability to human idiopathic pulmonary fibrosis. Exp Lung Res. 2015;41(2):57–73. doi:https://doi.org/10.3109/01902148.2014.979516
- Garg R, Aslam S, Garg A, Walia R. A prospective comparative study of serratiopeptidase and aceclofenac in upper and lower limb soft tissue trauma cases [internet]. Int J Pharmacol Pharmaceut Technol; 2012. [accessed 2020 Sep 14]. http://enzymeresearchgroup.s3.amazonaws.com/research/Serrapeptase/A+Prospective+Comparative+Study+of+Serratiopeptidase+and+Aceclofenac+in+Upper+and+Lower+Limb+Soft+Tissue+Trauma+Cases.pdf.
- Cortijo J, Cerdá -Nicolá M, Serrano A, Bioque G, Estrela J, Santangelo F, Esteras A, Llombart-Bosch A, Morcillo EJ. Attenuation by oral N-acetylcysteine of bleomycin-induced lung injury in rats. Eur Respir Soc. 2001.;17(6):1228–1235. doi: https://doi.org/10.1183/09031936.01.00049701
- Rendell R, Fairhall S, Graham S, Rutter S, Auton P, Smith A, Perrott R, Jugg B. Assessment of N-acetylcysteine as a therapy for phosgene-induced acute lung injury. Toxicol Lett. 2018;290:145–152. doi:https://doi.org/10.1016/j.toxlet.2018.03.025
- Shukla SK, Shukla SK, Govender PP, Giri NG. Biodegradable polymeric nanostructures in therapeutic applications: Opportunities and challenges. RSC Adv. 2016;6(97):94325–94351. doi:https://doi.org/10.1039/C6RA15764E
- Lobo V, Patil A, Phatak A. Reviews NC-P, 2010 U. Free radicals, antioxidants and functional foods: impact on human health. Pharmacogn Rev. 2010;4(8):118–126. doi:https://doi.org/10.4103/0973-7847.70902
- Matsuno O. Drug-induced interstitial lung disease: Mechanisms and best diagnostic approaches. Respir Res. 2012;13:39. doi:https://doi.org/10.1186/1465-9921-13-39
- Park H-H, Lee S, Oh J-M, Lee M-S, Yoon K-H, Park BH, Kim JW, Song H, Kim S-H. Anti-inflammatory activity of fisetin in human mast cells (HMC-1). Pharmacol Res. 2007;55(1):31–37. doi:https://doi.org/10.1016/j.phrs.2006.10.002
- Hirano T, Higa S, Arimitsu J, Naka T, Shima Y, Ohshima S, Fujimoto M, Yamadori T, Kawase I, Tanaka T, et al. Flavonoids such as luteolin, fisetin and apigenin are inhibitors of interleukin-4 and interleukin-13 production by activated human basophils. Int Arch Allergy Immunol. 2004;134(2):135–140. doi:https://doi.org/10.1159/000078498
- Banerjee ER, Kar S, Konsam S, Hore G, Mitra S, Biswas S, Sinha A, Jana NR. Therapeutic use of fisetin, curcumin, and mesoporous carbon nanoparticle loaded fisetin in bleomycin-induced idiopathic pulmonary fibrosis. Biomed Res Ther. 2015;2(4):250–262. doi:https://doi.org/10.7603/s40730-015-0010-4
- Kar S, Biswas S, Banerjee ER. Evaluating the ameliorative potential of plant flavonoids and their nanocomposites in bleomycin induced idiopathic pulmonary fibrosis. Biomed Res Ther. 2016;3(7):707–722. doi:https://doi.org/10.7603/s40730-016-0032-6
- Daba M, El-Tahir KE, Al-Arifi MG,Gubara OA . Drug-induced pulmonary fibrosis - PubMed. Saudi Med J. 2004;25(6):700–706.
- Van Barneveld PW, van der Mark TW, Sleijfer DT, Mulder NH, Koops HS, Sluiter HJ, Peset R. Predictive factors for bleomycin-induced pneumonitis. Am Rev Respir Dis. 1984;130(6):1078–1081. doi:https://doi.org/10.1164/arrd.1984.130.6.1078